Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |